Connect Biopharma Holdings (CNTB) Other Non-Current Assets (2020 - 2026)

Connect Biopharma Holdings (CNTB) has reported Other Non-Current Assets for 7 consecutive years, with $646000.0 the latest figure, recorded in Q1 2026.

• Quarterly Other Non-Current Assets rose 1335.56% year-over-year to $646000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $646000.0 (up 1335.56% YoY) and the FY2025 annual result came in at $646000.0, up 1857.58% from the prior year.
• Other Non-Current Assets held at $646000.0 in Q1 2026 per CNTB's latest filing, from $646000.0 in the prior quarter.
• Over the last five years, Other Non-Current Assets for CNTB reached as high as $835000.0 in Q2 2022 and fell as low as $24000.0 in Q4 2023.
• A 5-year average of $308965.4 and a median of $96000.0 in 2024 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets sank 91.62% — and 2025, when it soared 1857.58%.
• Year by year, Other Non-Current Assets stood at $246619.6 in 2022, then sank by 90.27% to $24000.0 in 2023, then jumped by 37.5% to $33000.0 in 2024, then surged by 1857.58% to $646000.0 in 2025, then changed by 0.0% to $646000.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $646000.0, $646000.0, and $45000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.